> and biologics stay at these 6-figure costs High healthcare cost is the entire reason we pay for health insurance. If treatments were cheaper, UNH would not b

> and biologics stay at these 6-figure costs High healthcare cost is the entire reason we pay for health insurance. If treatments were cheaper, UNH would not be worth half a trillion dollars. Put another way, this is exactly what UNH signed up for. They actively lobby against efforts to reduce healthcare costs at the expense of their profits, which largely derive from amortizing the risk that some of their customers will have treatments too expensive for them to afford. As an analogy, a home insurer doesn't get sympathy when they try to dodge rebuilding costs after a fire or other disaster reduces their profits. The insurer explicitly signed up for the job of paying for the rebuilds, and that was not contingent on the cost of the hypothetical future rebuilds. They have the scale to influence healthcare costs through means other than denying claims. And they have the financial heft to (for example) buy makers of expensive niche treatments if they dislike other market participants capturing healthcare dollars. TL;DR; this is a problem entirely of UNH's own making, for which they are well compensated by the markets. Regulators should not allow them to operate in our regulated markets in this manner.